Yuanyuan Zhao

Camrelizumab (SHR-1210) alone or in combination with gemcitabine plus cisplatin for nasopharyngeal carcinoma: results from two single-arm, phase 1 trials

Wenfeng Fang, Yunpeng Yang, Yuxiang Ma et al. · The Lancet Oncology · 2018 · 495 citations

Medicine, Immunology, Pathology +8

EBV-driven LMP1 and IFN-γ up-regulate PD-L1 in nasopharyngeal carcinoma: Implications for oncotargeted therapy

Wenfeng Fang, Jianwei Zhang, Shaodong Hong et al. · Oncotarget · 2014 · 382 citations · Full text

Immunology, Immune Regulation, Cell Death +22

Genomic Analysis of Nasopharyngeal Carcinoma Reveals TME-Based Subtypes

Li Zhang, Kenzie D. MacIsaac, Ting Zhou et al. · Molecular Cancer Research · 2017 · 212 citations

Tislelizumab plus chemotherapy as first-line treatment for recurrent or metastatic nasopharyngeal cancer: A multicenter phase 3 trial (RATIONALE-309)

Yunpeng Yang, Jianji Pan, Hui Wang et al. · Cancer Cell · 2023 · 191 citations · Full text

R/m Npc, Immunology, Pathology +16

Ratio of C-Reactive Protein/Albumin is An Inflammatory Prognostic Score for Predicting Overall Survival of Patients with Small-cell Lung Cancer

Ting Zhou, Jianhua Zhan, Shaodong Hong et al. · Scientific Reports · 2015 · 160 citations · Full text